Genetics, genomics and metabolomics: New insights into maternal metabolism during pregnancy

Diabetic Medicine

Volumn 31, Issue 3, 2014, Pages 254-262

  Lowe, W L ^a   Karban, J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT, NEWBORN; INSULIN RESISTANCE; METABOLOMICS; PREGNANCY; PREGNANT WOMEN;

EID: 84894081964     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12352     Document Type: Review

References (57)

1. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000; 71: 1256S-1261S.
2. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007; 50: 938-948.
3. Hadden DR, McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med 2009; 14: 66-71.
4. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
5. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007; 30: 2287-2292.
6. Pettitt DJ, Knowler WC. Long-term effects of the intrauterine environment, birthweight, and breast-feeding in Pima Indians. Diabetes Care 1998; 21: B138-141.
7. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003; 19: 259-270.
8. Desoye G. Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 2007; 30: S120-126.
9. Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011; 18: 409-416.
10. Butler AE, Cao-Minh L, Galasso R, Rizza RA, Corradin A, Cobelli C et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010; 53: 2167-2176.
11. Mills JL, Jovanovic L, Knopp R, Aarons J, Conley M, Park E et al. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the Diabetes in Early Pregnancy Study. Metabolism 1998; 47: 1140-1144.
12. Kalhan SC. Protein metabolism in pregnancy. Am J Clin Nutr 2000; 71: 1249S-1255S.
13. Mills GW, Avery PJ, McCarthy MI, Hattersley AT, Levy JC, Hitman GA et al. Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia 2004; 47: 732-738.
14. Schousboe K, Visscher PM, Henriksen JE, Hopper JL, Sorensen TI, Kyvik KO. Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia 2003; 46: 1276-1283.
15. Robitaille J, Grant AM. The genetics of gestational diabetes mellitus: evidence for relationship with type 2 diabetes mellitus. Genet Med 2008; 10: 240-250.
16. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010; 363: 166-176.
17. Watanabe RM. Inherited destiny? Genetics and gestational diabetes mellitus. Genome Med 2011; 3: 18.
18. Zhang C, Bao W, Rong Y, Yang H, Bowers K, Yeung E et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update 2013; 19: 376-390.
19. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115: 485-491.
20. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012; 44: 981-990.
21. Mao H, Li Q, Gao S. Meta-analysis of the relationship between common Type 2 diabetes risk gene variants with gestational diabetes mellitus. PLoS One 2012; 7: e45882.
22. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012; 44: 991-1005.
23. Kwak SH, Kim SH, Cho YM, Go MJ, Cho YS, Choi SH et al. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 2012; 61: 531-541.
24. Barker A, Langenberg C, Wareham NJ. Genetic determinants of glucose homeostasis. Best Pract Res Clin Endocrinol Metab 2012; 26: 159-170.
25. Weedon MN, Clark VJ, Qian Y, Ben-Shlomo Y, Timpson N, Ebrahim S et al. A common haplotype of the glucokinase gene alters fasting glucose and birthweight: association in six studies and population-genetics analyses. Am J Hum Genet 2006; 79: 991-1001.
26. Freathy RM, Hayes MG, Urbanek M, Lowe LP, Lee H, Ackerman C et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and post-challenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from the International Association of Diabetes and Pregnancy Study Groups. Diabetes 2010; 59: 2682-2689.
27. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42: 105-116.
28. Freathy RM, Weedon MN, Bennett A, Hypponen E, Relton CL, Knight B et al. Type 2 diabetes TCF7L2 risk genotypes alter birthweight: a study of 24 053 individuals. Am J Hum Genet 2007; 80: 1150-1161.
29. Lowe LP, Metzger BE, Lowe WL Jr, Dyer AR, McDade TW, McIntyre HD. Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. J Clin Endocrinol Metab 2010; 95: 5427-5434.
30. Urbanek M, Hayes MG, Lee H, Freathy RM, Lowe LP, Ackerman C et al. The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy. PLoS One 2012; 7: e32958.
31. Hayes MG, Urbanek M, Hivert MF, Armstrong LL, Morrison J, Guo C et al. Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies. Diabetes 2013; 62: 3282-3291.
32. Liao S, Liu Y, Tan Y, Gan L, Mei J, Song W et al. Association of genetic variants of melatonin receptor 1B with gestational plasma glucose level and risk of glucose intolerance in pregnant Chinese women. PLoS One 2012; 7: e40113.
33. Irwin DM, Tan H. Molecular evolution of the vertebrate hexokinase gene family: Identification of a conserved fifth vertebrate hexokinase gene. Comp Biochem Physiol Part D Genomics Proteomics 2008; 3: 96-107.
34. Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H. BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein. Proc Natl Acad Sci U S A 2000; 97: 9712-9717.
35. Bennett BD, Babu-Khan S, Loeloff R, Louis JC, Curran E, Citron M et al. Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem 2000; 275: 20647-20651.
36. Casas S, Casini P, Piquer S, Altirriba J, Soty M, Cadavez L et al. BACE2 plays a role in the insulin receptor trafficking in pancreatic ss-cells. Am J Physiol Endocrinol Metab 2010; 299: E1087-1095.
37. Esterhazy D, Stutzer I, Wang H, Rechsteiner MP, Beauchamp J, Dobeli H et al. Bace2 is a β-cell-enriched protease that regulates pancreatic β-cell function and mass. Cell Metab 2011; 14: 365-377.
38. Petry CJ, Ong KK, Dunger DB. Does the fetal genotype affect maternal physiology during pregnancy? Trends Mol Med 2007; 13: 414-421.
39. Petry CJ, Seear RV, Wingate DL, Manico L, Acerini CL, Ong KK et al. Associations between paternally transmitted fetal IGF2 variants and maternal circulating glucose concentrations in pregnancy. Diabetes 2011; 60: 3090-3096.
40. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012; 13: 263-269.
41. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S et al. The human serum metabolome. PLoS One 2011; 6: e16957.
42. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB. Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 2009; 58: 2429-2443.
43. Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell 2008; 134: 714-717.
44. Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, Tikkanen E, Lyytikainen LP et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 2012; 44: 269-276.
45. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241214.
46. Diaz SO, Pinto J, Graca G, Duarte IF, Barros AS, Galhano E et al. Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. J Proteome Res 2011; 10: 3732-3742.
47. Graca G, Goodfellow BJ, Barros AS, Diaz S, Duarte IF, Spagou K et al. UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers. Mol Biosyst 2012; 8: 1243-1254.
48. Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, Adam KP et al. Early metabolic markers of the development of dysglycemia and Type 2 diabetes and their physiological significance. Diabetes 2013; 62: 1730-1737.
49. Sachse D, Sletner L, Morkrid K, Jenum AK, Birkeland KI, Rise F et al. Metabolic changes in urine during and after pregnancy in a large, multi-ethnic population-based cohort study of gestational diabetes. PLoS One 2012; 7: e52399.
50. Scholtens DM, Muehlbauer MJ, Daya NR, Stevens RD, Dyer AR, Lowe LP et al. Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy. Diabetes Care 2014; 37: 158-166.
51. Wurtz P, Makinen VP, Soininen P, Kangas AJ, Tukiainen T, Kettunen J et al. Metabolic signatures of insulin resistance in 7098 young adults. Diabetes 2012; 61: 1372-1380.
52. Cetin I, de Santis MS, Taricco E, Radaelli T, Teng C, Ronzoni S et al. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am J Obstet Gynecol 2005; 192: 610-617.
53. Metzger BE, Phelps RL, Freinkel N, Navickas IA. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care 1980; 3: 402-409.
54. Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 2012; 15: 606-614.
55. Stancakova A, Civelek M, Saleem NK, Soininen P, Kangas AJ, Cederberg H et al. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9369 Finnish men. Diabetes 2012; 61: 1895-1902.
56. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17: 448-453.
57. Adeva MM, Calvino J, Souto G, Donapetry C. Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids 2012; 43: 171-181.